Corrigendum to "A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma" [EBioMedicine 41 (2019) 244-255]
EBioMedicine. 2019 May:43:650.
doi: 10.1016/j.ebiom.2019.05.001.
Epub 2019 May 14.
1 Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
2 Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing, China.
3 Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: qiminzhan@vip.163.com.